Arformoterol Tartrate Solution
Product Images NDC 50742-395

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 50742-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Outercarton60 (20250305111738)

The packaging label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL, produced by Ingenus Pharmaceuticals, LLC. The label indicates it is for oral inhalation only, available in 60 sterile unit-dose vials of 2 mL each, packaged as 12 pouches containing 5 unit-dose vials. Storage instructions specify refrigeration or room temperature for up to 6 weeks. The label includes the NDC 50742-395-60, a barcode, and manufacturer information from Orlando, FL, USA.*

FDA Label Image

Outercarton30 (20250305111923)

The packaging label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by Ingenus Pharmaceuticals, LLC. It indicates the product is for oral inhalation only, containing 30 sterile unit-dose vials of 2 mL each, packaged as 6 pouches of 5 vials. Storage instructions specify refrigeration or room temperature for up to 6 weeks. The label includes a barcode and manufacturer details.*

FDA Label Image

Image 1 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 1)

An instructional illustration showing hands removing the protective cap from a vial by twisting it open, likely for a respiratory inhalation solution such as Arformoterol Tartrate 15 ug/2mL.*

FDA Label Image

Image 2 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 2)

An instructional illustration showing a hand holding a vial above a respiratory device with a labeled reservoir, demonstrating how to fill the reservoir with the solution for inhalation use.*

FDA Label Image

Image 3 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 3)

An instructional diagram showing a respiratory inhalation device with a labeled mouthpiece. The device features a cylindrical body with a handle and a connecting tube protruding downward, indicating where the mouthpiece attaches for inhalation use.*

FDA Label Image

Image 4 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 4)

An instructional illustration showing a face mask placed on a person's face connected to a respiratory inhalation device, indicating proper use for medication delivery.*

FDA Label Image

Image 5 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 5)

An instructional illustration showing a tubing connected to a compressor device, highlighting the connection point for respiratory inhalation use.*

FDA Label Image

Image 6 (27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 6)

Illustration showing a person using a respiratory inhalation device, demonstrating how to place the mouth on the inhaler mouthpiece to administer the medication.*

FDA Label Image

Clinical Figure 1 (Clinical Figure 1)

Line graph displaying mean change from baseline FEV1 (L) over 12 hours postdose. Two lines represent placebo and 15 mcg arformoterol tartrate inhalation solution BID groups, showing greater improvements in FEV1 with arformoterol compared to placebo throughout the time period.*

FDA Label Image

Clinical Figure 1 (Clinical Figure 2)

A line graph showing mean change from baseline FEV1 (liters) over 12 hours postdose comparing placebo and 15 mcg Arformoterol Tartrate inhalation solution BID. The y-axis represents change in FEV1, and the x-axis shows hours postdose. The treatment group shows a higher increase in FEV1 compared to placebo, peaking early and gradually declining but remaining above baseline.*

FDA Label Image

Logo (Ingenus Logo)

FDA Label Image

Structure (Structure)

Chemical structure of Arformoterol Tartrate showing the molecular arrangement of its components, including the arformoterol molecule and the tartrate moiety, as depicted in a line drawing format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.